
3.62BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
CA98420N1050
CUSIP
98420N105
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-0.06
Book Value
12.84
Dividend Share
-
Dividend Yield
-
Earnings Share
-4.74
Wall Street Target Price
71.75
EPS Estimate Current Year
-4.63
EPS Estimate Next Year
-4.72
EPS Estimate Current Quarter
-1.1612
EPS Estimate Next Quarter
-1.1944
Most Recent Quarter
-
Revenue TTM
0
Gross Profit TTM
-352,484,992
EBITDA
-439,188,992
Profit Margin
0.00%
Return On Assets TTM
-28.02%
Return On Equity TTM
-43.62%
Revenue Per Share TTM
0
Qtly Revenue Growth YOY
-100.00%
Diluted Eps TTM
-4.74
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
727.4404
Price Book MRQ
2.916
Enterprise Value Revenue
649
Enterprise Value EBITDA
34
903.08
3.20%227.40
2.97%965.00
0.55%314.92
0.35%900.30
0.00%139.16
0.00%528.21
-4.77%355.10
-2.26%34.64
-2.01%153.70
-1.47%